Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation.

Le PH, Kuo CJ, Hsieh YC, Chen TH, Lin CL, Yeh CT, Liang KH.

BMC Cancer. 2019 Dec 5;19(1):1190. doi: 10.1186/s12885-019-6409-3.

PMID:
31805979
2.

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?

Lee CW, Tsai HI, Lee WC, Huang SW, Lin CY, Hsieh YC, Kuo T, Chen CW, Yu MC.

J Clin Med. 2019 Oct 19;8(10). pii: E1736. doi: 10.3390/jcm8101736.

3.
4.

The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.

Lin PT, Teng W, Jeng WJ, Hsieh YC, Hung CF, Huang CH, Lui KW, Chen YC, Lin CC, Lin SM, Sheen IS, Lin CY.

J Formos Med Assoc. 2019 Sep 5. pii: S0929-6646(19)30227-X. doi: 10.1016/j.jfma.2019.08.019. [Epub ahead of print]

5.

Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients.

Kou HW, Yeh CH, Tsai HI, Hsu CC, Hsieh YC, Chen WT, Cheng HT, Yu MC, Lee CW.

PLoS One. 2019 Aug 8;14(8):e0220699. doi: 10.1371/journal.pone.0220699. eCollection 2019.

6.

Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?

Lee CW, Chan KM, Tsai HI, Hsieh YC, Lin CY, Kuo YC, Hsu HY, Yu MC.

Aging (Albany NY). 2019 Mar 13;11(5):1537-1550. doi: 10.18632/aging.101854.

7.

Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients.

Chen YC, Teng W, Hsieh YC, Chen WT, Jeng WJ, Huang CH, Lin CC, Chen YC, Lin SM, Lin CY, Sheen IS.

J Formos Med Assoc. 2019 Aug;118(8):1239-1246. doi: 10.1016/j.jfma.2018.11.014. Epub 2018 Dec 21.

8.

Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations.

Hsieh YC, Limquiaco JL, Lin CC, Chen WT, Lin SM.

Abdom Radiol (NY). 2019 Mar;44(3):1141-1151. doi: 10.1007/s00261-018-1831-6.

PMID:
30460530
9.

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis.

Hsieh YC, Jeng WJ, Huang CH, Teng W, Chen WT, Chen YC, Lin SM, Tai DI, Lin CY, Sheen IS.

PLoS One. 2018 Aug 23;13(8):e0202777. doi: 10.1371/journal.pone.0202777. eCollection 2018.

10.

Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.

Hu CC, Jeng WJ, Chen YC, Fang JH, Huang CH, Teng W, Hsieh YC, Lin YC, Chien RN, Sheen IS, Lin CY.

Sci Rep. 2017 Nov 10;7(1):15280. doi: 10.1038/s41598-017-15527-x.

11.

Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients.

Huang CH, Jeng WJ, Ho YP, Teng W, Hsieh YC, Chen WT, Chen YC, Lin HH, Sheen IS, Lin CY.

Sci Rep. 2016 Dec 1;6:38250. doi: 10.1038/srep38250.

12.

Trend analysis and future development of Taiwan electronic medical records.

Ke WC, Hsieh YC, Chen YC, Lin ET, Chiu HW.

Stud Health Technol Inform. 2012;180:1230-2.

PMID:
22874410
13.

Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.

Chang FR, Hsieh YC, Chang YF, Lee KH, Wu YC, Chang LK.

Antiviral Res. 2010 Mar;85(3):490-5. doi: 10.1016/j.antiviral.2009.12.002. Epub 2009 Dec 5.

PMID:
19969023

Supplemental Content

Loading ...
Support Center